Mid-trimester fetal livers are a rich source of CD34(+/++) cells for transplantation

Bone Marrow Transplantation

Volumn 24, Issue 5, 1999, Pages 451-461

  Golfier, F ^a,b,c   Barcena A ^a   Cruz, J ^b   Harrison, M R ^a   Muench, M O ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HÔTEL DIEU   (France)

Author keywords

CD34+ cells; Fetal tissue transplantation; Hematopoietic stem cells; Liver

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN;

ARTICLE; CELL COUNT; CELL ISOLATION; CELL MATURATION; CELL SELECTION; COLONY FORMING UNIT; FETAL TISSUE TRANSPLANTATION; FETUS; FETUS LIVER; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRENATAL CARE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STEM CELL; T LYMPHOCYTE;

EID: 0344980831     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701940     Document Type: Article

References (61)

1. Touraine JL, Raudrant D, Royo C et al. In utero transplantation of stem cells in bare lymphocyte syndrome. Lancet 1989; 1: 1382.
2. Cappellini MD, Potter CG, Wood WG. Long-term haemopoiesis in human fetal liver cell cultures. Br J Haematol 1984; 57: 61-70.
3. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787-791.
4. Touraine JL. In utero transplantation of fetal liver stem cells in humans. Blood Cells 1991; 17: 379-387.
5. Touraine JL, Raudrant D, Royo C et al. In utero transplantation of hemopoietic stem cells in humans. Transplant Proc 1991; 23: 1706-1708.
6. Touraine JL. Transplantation of fetal liver stem cells into patients and into human fetuses, with induction of immunologic tolerance. Transplant Proc 1993; 25: 1012-1013.
7. Touraine JL, Raudrant D. In utero stem cell therapy using fetal cells transplanted into fetal recipients. In: Levitt D, Mertelsman R (eds). Hematopoietic Stem Cells: Biology and Therapeutic Applications. Marcel Dekker: New York, 1995, pp 369-390.
8. Touraine JL. Treatment of human fetuses and induction of immunological tolerance in humans by in utero transplantation of stem cells into fetal recipients. Acta Haematol 1996; 96: 115-119.
9. Mychaliska GB, Muench MO, Rice HE et al. The biology and ethics of banking fetal liver hematopoietic stem cells for in utero transplantation. J Ped Surg 1998; 33: 394-399.
10. Barcena A, Muench MO, Galy AHM et al. Phenotypic and functional analysis of T cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T-and myeloid-cell development. Blood 1993; 82: 3401-3414.
11. + human fetal liver progenitors with a high proliferative potential. Blood 1994; 83: 3170-3181.
12. Denning-Kendall P, Donaldson C, Nicol A et al. Optimal processing of human umbilical cord blood for clinical banking. Exp Hematol 1996; 24: 1394-1401.
13. Muench MO, Roncarolo MG, Menon S et al. FLK-2/FLT-3 ligand (FL) regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995; 85: 963-972.
14. Valtieri M, Gabbianelli M, Pelosi E et al. Erythropoietin alone induces burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture. Blood 1989; 74: 460-470.
15. Muench MO, Schneider JG, Moore MAS. Interactions among colony-stimulating factors, IL-1β, IL-6 and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 1992; 20: 339-349.
16. Rowley PT, Ohlsson-Wilhelm BM, Farley BA. Erythroid colony formation from human fetal liver. Proc Natl Acad Sci USA 1978; 75: 984-988.
17. - progenitor cells. Blood 1991; 77: 1218-1227.
18. + hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood 1994; 84: 1896-1905.
19. Louache F, Debili N, Marandin A et al. Expression of CD4 by human hematopoietic progenitors. Blood 1994; 84: 3344-3355.
20. Muench MO, Roncarolo MG, Namikawa R. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood 1997; 89: 1364-1375.
21. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
22. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804-2808.
23. + cell dose predicts survival, post-transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223-3229.
24. + Thy-1 dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
25. + hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. Exp Hematol 1994; 22: 1134-1140.
26. Gordon MY, Blackett NM. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant 1995; 15: 659-662.
27. Anderson EM, Jones DR, Liu DT, Evans AA. Gestational age and cell viability determine the effect of frozen storage on human fetal hematopoietic progenitor cell preparations. Fetal Diagn Ther 1996; 11: 427-432.
28. Metcalf D, Moore MAS. Embryonic aspects of hemopoiesis. In: Neuberger A, Taturn EL (eds). Frontiers of Biology. Hematopoietic Cells. North Holland: Amsterdam, 1971, pp 457-472.
29. Charbord P, Tavian M, Humeau L, Peault B. Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood 1996; 87: 4109-4119.
30. - progenitor cells in long-term cultures and semisolid assays. Blood 1993; 81: 2916-2924.
31. Humeau L, Chabannon C, Firpo MT et al. Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood 1997; 90: 3496-3506.
32. Roy V, Miller JS, Verfaillie CM. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp Hematol 1997; 25: 387-394.
33. Kögler G, Callejas J, Hakenberg P et al. Hematopoietic transplant potential of unrelated cord blood: critical issues. J Hematother 1996; 5: 105-116.
34. Kletzel M, Haut P, Atlas M et al. Red cell depletion of umbilical cord blood (UCB): comparison between unmanipulated and red cell-depleted UCB by Ficoll-Paque density gradient separation. J Hematother 1997; 6: 269-272.
35. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
36. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
37. Koumakis G, Fills J, Vassilomanolakis M et al. Relation between hematological recovery and number of transplanted mononuclear cells in patients after high dose chemotherapy with peripheral blood stem cell rescue. Blood Cells Mol Dis 1995; 21: 235-238.
38. + cells purified after cryopreservation. Exp Hematol 1995; 23: 1589-1594.
39. Jones RJ, Celano P, Sharkis SJ, Sensenbrenner LL. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 1989; 73: 397-401.
40. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
41. Vallera DA, Blazar BR. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 1989; 47: 751-760.
42. Rice HE, Hedrick MH, Flake AW et al. Bacterial and fungal contamination of human fetal liver collected transvaginally for hematopoietic stem cell transplantation. Fetal Diagn Ther 1993; 8: 74-78.
43. Rice HE, Skarsgard ED, Emani VR et al. An effective strategy for decontamination, ex vivo expansion, and storage of human fetal liver hematopoietic stem cells. Transplant Proc 1994; 26: 3352-3353.
44. Rowley SD, Davis J, Dick J et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Transfusion 1988; 28: 109-112.
45. D'Antonio D, Iacone A, Fioritoni G et al, Detection of bacterial contamination in bone marrow graft. Haematologica 1991; 76(Suppl. 1): 44-45.
46. Lazarus HM, Magalhaes-Silverman M, Fox RM et al. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991; 7: 241-246.
47. Stroncek DF, Fautsch SK, Lasky LC et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521-526.
48. Schwella N, Zimmermann R, Heuft HG et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994; 67: 32-35.
49. Prince HM, Page SR, Keating A et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995; 15: 87-91.
50. Webb IJ, Coral FS, Andersen JW et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996; 36: 782-788.
51. Prümmer O, Werner C, Raghavachar A et al. Fetal liver transplantation in the dog. II. Repopulation of the granulocytemacrophage progenitor cell compartment by fetal liver cells from DLA-identical siblings. Transplantation 1985; 40: 498-503.
52. Prümmer O, Calvo W, Werner C et al. Hemopoiesis and immune functions in dogs following fetal liver transplantation. Prog Clin Biol Res 1985; 193: 175-194.
53. Prümmer O, Raghavachar A, Werner C et al. Fetal liver transplantation in the dog. I. Restoration of hemopoiesis with cryopreserved fetal liver cells from DLA-identical siblings. Transplantation 1985; 39: 349-355.
54. Cain GR, Champlin RE, Gale RP. Survival and immune recovery in dogs following fetal liver transplantation. Transplant Proc 1987; 19: 2695-2697.
55. Cain G, Stitzel K, Gale R, Champlin R. Transplantation of DLA-compatible and incompatible fetal liver hematopoietic cells in dogs. Transplantation 1987; 44: 742-747.
56. Cain GR, Champlin RE. Long-term complete chimerism and stable hematopoiesis in beagles after fetal liver hematopoietic stem cell transplantation. Am J Vet Res 1989; 50: 1282-1284.
57. Rebel VI, Miller CL, Thornbury GR et al. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. Exp Hematol 1996; 24: 638-648.
58. Harrison DE, Zhong RK, Jordan CT et al. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol 1997; 25: 293-297.
59. Roy V, Verfaillie CM. Soluble factor(s) produced by adult bone marrow stroma inhibit in vitro proliferation and differentiation of fetal liver BFU-E by inducing apoptosis. J Clin Invest 1997; 100: 912-920.
60. Roy V, Verfaillie CM. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol 1999; 27: 302-312.
61. Muench MO, Roncarolo M-G, Namikawa R et al. Progress in the ex vivo expansion of hematopoietic progenitors. Leuk Lymphoma 1994; 16: 1-11.